GENE ONLINE|News &
Opinion
Blog

2018-10-04| PartnerAsia-Pacific

【Event Information】Med x Tech Summit Asia (MEDTEX) will debut on Nov 29th – 30th in Taipei, Taiwan!

by GeneOnline
Share To

From AIoT, Blockchain, Gene Editing, Cell Therapy, to Immune-Oncology, MEDTEX brings over 30 cross-industry global key opinion leaders to Taipei.

MEDTEX welcomes world-renowned experts Including Microsoft, Google AI, Takeda, Mayo Clinic, Merck, Teva, Harvard Medical School, NVIDIA, etc. to discuss Immune-Oncology, Delivering Personalized Healthcare through Precision Medicine, Intelligent Healthcare, Blockchain, Big Data, and other popular topics in this intensive 2-day event.

Taiwan Healthcare+ Expo is the signature expo in Asia Pacific that provides solutions for medicine, health, and care. Starting from all aspects of healthcare needs, the expo strategically connects electronics, IT, biotech, pharmaceuticals, medical devices, precision machinery, precision medicine, health management industries along with the biomedical innovators from Israel, US, Germany, Singapore, Australia together.

With 400+ major medical centers, technology, pharmaceutical, medical devices organizations participating, MEDTEX and Healthcare+ Expo are for medical professionals, IT, device, pharmaceutical, and biotech companies who wants to find new opportunities and partnering with global healthcare industry players in Asia. All expo attendees also have the opportunity to participate in the optional B2B Partnering Program.

Don’t wait till its’ too late! Come and join us, register now!

Time: Nov 29 (Thur) – 30 (Fri)
Location: Grande Luxe Banquet (Flagship)
MEDTEX Info: https://bit.ly/2NUNbIg

 

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
R&D
Merck’s KEYTRUDA Fails in Early-Stage Lung and Skin Cancer Trials, Ends Two Phase 3 Studies
2024-08-30
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top